Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

Catalyst Pharmaceutical  Inc.

Catalyst Pharmaceuticals is focused on developing therapies for rare and ultra-rare diseases.

COM:CATALYSTPHARMA

Catalyst Pharmaceuticals, Inc.

Last Close

21.12

22/11 21:00

Market Cap

2.56B

Beta: -

Volume Today

863.01K

Avg: -